Central Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, 5000, South Australia.
School of Pharmacy and Medical Sciences, Sansom Institute, University of South Australia, Adelaide, 5000, South Australia.
Stem Cell Res Ther. 2018 Jul 11;9(1):189. doi: 10.1186/s13287-018-0932-z.
Desirable cells for human cell therapy would be ones that can be generated by simple isolation and culture techniques using a donor sample obtained by non-invasive methods. To date, the different donor-specific cells that can be isolated from blood, skin, and hair require invasive methods for sample isolation and incorporate complex and costly reagents to culture. These cells also take considerable time for their in-vitro isolation and expansion. Previous studies suggest that donor-derived cells, namely urine stem cells and renal cells, may be isolated from human urine samples using a cost-effective and simple method of isolation, incorporating not such complex reagents. Moreover, the isolated cells, particularly urine stem cells, are superior to conventional stem cell sources in terms of favourable gene profile and inherent multipotent potential. Transdifferentiation or differentiation of human urine-derived cells can generate desirable cells for regenerative therapy. In this review, we intended to discuss the characteristics and therapeutic applications of urine-derived cells for human cell therapy. Conclusively, with detailed study and optimisation, urine-derived cells have a prospective future to generate functional lineage-specific cells for patients from a clinical translation point of view.
用于人类细胞治疗的理想细胞应该是那些可以通过简单的分离和培养技术,使用非侵入性方法获得的供体样本进行生成的。迄今为止,可以从血液、皮肤和头发中分离出的不同供体特异性细胞需要侵入性的样本分离方法,并结合复杂且昂贵的试剂进行培养。这些细胞在体外分离和扩增也需要相当长的时间。先前的研究表明,使用一种具有成本效益且简单的分离方法,结合不那么复杂的试剂,可能可以从人类尿液样本中分离出供体来源的细胞,即尿液干细胞和肾细胞。此外,分离出的细胞,特别是尿液干细胞,在有利的基因谱和内在多能性潜力方面优于传统的干细胞来源。人尿液来源细胞的转分化或分化可以产生用于再生治疗的理想细胞。在这篇综述中,我们旨在讨论尿液来源细胞的特性和治疗应用,用于人类细胞治疗。总之,从临床转化的角度来看,随着详细的研究和优化,尿液来源细胞具有为患者生成功能性谱系特异性细胞的广阔前景。